neuro-ophthalmology

Advertisement

cGxPJobs Banner

Oculis Highlights Late-Stage Eye Pipeline at AAO 2025

October 14, 2025 | Zug, Switzerland — Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company advancing therapies for...

By cGxPwire Editor
October 14, 2025

Read More

Advertisement

cGxPJobs

Directory